| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/24/2007 | EP1745073A2 Cell surface receptor isoforms and methods of identifying and using the same |
| 01/24/2007 | EP1745071A2 Msh-agonist tripeptide conjugates |
| 01/24/2007 | EP1745069A2 Therapeutic use of a growth factor, nsg33 |
| 01/24/2007 | EP1745065A1 Antimicrobial polypeptides |
| 01/24/2007 | EP1745064A2 Compounds for proteasome enzyme inhibition |
| 01/24/2007 | EP1744779A2 Lytic enzymes and spore surface antigen for detection and treatment of "bacillus anthracis" bacteria and spores |
| 01/24/2007 | EP1744778A1 Use of growth hormone in treatment of long-bone fractures |
| 01/24/2007 | EP1744777A2 Use of il-6 in the preparation of pharmaceutical compositions for treating and preventing liver injury |
| 01/24/2007 | EP1744776A2 Neurotransmitter mixture which promotes the healing of wounds |
| 01/24/2007 | EP1744761A1 Methods for treating or preventing restenosis and other vascular proliferative disorders |
| 01/24/2007 | EP1744749A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 01/24/2007 | EP1744737A2 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 01/24/2007 | EP1744734A2 Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds |
| 01/24/2007 | EP1744728A1 Tissue enhancement implant and method |
| 01/24/2007 | EP1744683A2 Apparatus and method for transdermal delivery of parathyroid hormone agents |
| 01/24/2007 | EP1615640B1 Antineoplastic combinations |
| 01/24/2007 | EP1565485B1 Perindopril |
| 01/24/2007 | EP1503714A4 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 01/24/2007 | EP1481007B1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom |
| 01/24/2007 | EP1461070B1 Combined use of a glp-1 compound and an aldose reductase inhibitor |
| 01/24/2007 | EP1390405B1 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 01/24/2007 | EP1374901B1 Graft rejection suppressors |
| 01/24/2007 | EP1284750B1 Pharmaceutical composition |
| 01/24/2007 | EP1280531B1 Formulation consisting of phentolamine mesylate and the use thereof |
| 01/24/2007 | EP1265920B9 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 01/24/2007 | EP1259627B1 Heterologous expression of neisserial proteins |
| 01/24/2007 | EP1257285B1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/24/2007 | EP1238092B1 Bovine immunodeficiency virus (biv) based vectors |
| 01/24/2007 | EP1181363B1 Recombinant human mannan-binding lectin |
| 01/24/2007 | EP1180525B1 Transcriptional activation inhibitory protein |
| 01/24/2007 | EP1123414B1 Antisense modulation of integrin alpha 4 expression |
| 01/24/2007 | EP1056845B1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 01/24/2007 | EP1049712B1 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/24/2007 | EP1003777B1 PGC-1, A NOVEL BROWN FAT PPARgamma COACTIVATOR |
| 01/24/2007 | EP0973799B1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/24/2007 | EP0970213B1 Death domain containing receptor 5 |
| 01/24/2007 | EP0951536B1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 01/24/2007 | EP0946727B1 Antibody mutants |
| 01/24/2007 | EP0941341B1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 01/24/2007 | EP0935001B9 Novel vegf-like factors |
| 01/24/2007 | EP0811073B1 Use of immune modulators for making medicaments ot inhibit immune responses against co-administered recombinant viruses |
| 01/24/2007 | EP0760000B1 Alphavirus expression vector |
| 01/24/2007 | EP0758383B1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 01/24/2007 | CN2860400Y Progestogen slow releasing bolt device |
| 01/24/2007 | CN1902313A Wt1-origin HLA-DR-binding antigen peptide |
| 01/24/2007 | CN1902307A Tissue regeneration method |
| 01/24/2007 | CN1902227A TIM-3 ligands and methods thereof |
| 01/24/2007 | CN1902226A Single-chain insulin |
| 01/24/2007 | CN1902223A Antiviral compositions which inhibit paramyxovirus infection |
| 01/24/2007 | CN1902222A Fc-erythropoietin fusion protein with improved pharmacokinetics |
| 01/24/2007 | CN1902221A Neutralizing epitope-based growth enhancing vaccine |
| 01/24/2007 | CN1902217A Novel peptide, process for producing the same and pharmaceutical composition containing the peptide |
| 01/24/2007 | CN1902216A Depeptidized inhibitors of hepatitis c virus NS3 protease |
| 01/24/2007 | CN1901934A Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases |
| 01/24/2007 | CN1901933A Methods of stimulating innate immunity using cationic peptides |
| 01/24/2007 | CN1901932A Cytokine antagonist molecules |
| 01/24/2007 | CN1901931A HIV gp41 hr2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus |
| 01/24/2007 | CN1901930A Integrin alphaiibbeta3 specific antibodies and peptides |
| 01/24/2007 | CN1901924A Method for inhibiting bacterial colonisation |
| 01/24/2007 | CN1901909A Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration |
| 01/24/2007 | CN1901903A Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders |
| 01/24/2007 | CN1901899A Methods of using and compositions comprising pde4 modulators for the treatment and management of asbestos-related diseases and disorders |
| 01/24/2007 | CN1901895A Methods of treating cancer with hdac inhibitors |
| 01/24/2007 | CN1901892A Treating infectious diseases using ice inhibitors |
| 01/24/2007 | CN1901886A Method for preparing solid dosage form of desmopressin |
| 01/24/2007 | CN1901863A Methods and reagents for the treatment of inflammatory disorders |
| 01/24/2007 | CN1900292A Solid fermenting method for vitacoenzyme medicine |
| 01/24/2007 | CN1900279A Polynucleotide for inducing apoptosis and its coded polypeptide and use |
| 01/24/2007 | CN1900274A Recombinant malignant malarial parasite hypoxanthine-guanine-xanthine phosphoribosyl transferase and its preparing method and use |
| 01/24/2007 | CN1900116A Anti-lymphotoxin-beta receptor antibodies, pharmaceutical composition containing the same and pharmaceutical application thereof |
| 01/24/2007 | CN1900110A Octreotide allosteric peptide molecule and its medicine |
| 01/24/2007 | CN1900109A Amolops loloensis insulin release promoting peptide and use in producing medicine |
| 01/24/2007 | CN1900108A Chronic myelogenous leukemia cell KT-1/A3 specific targeting short peptide series and its sieving |
| 01/24/2007 | CN1899606A Component for preventing and controlling heart diseases |
| 01/24/2007 | CN1899605A New use of granulocyte-macrophage stimulating factor treating cerricitis and cervical erosion |
| 01/24/2007 | CN1899604A Rectal suppository of protein medicines and its preparing method and use in systemic disease therapy |
| 01/24/2007 | CN1899603A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 01/24/2007 | CN1899602A RanBPM important function in nervous system |
| 01/24/2007 | CN1899601A Antibiotic peptide Babu plaster and its preparing method |
| 01/24/2007 | CN1899600A Antibiotic peptide spray film forming agent and its preparing method |
| 01/24/2007 | CN1899599A Method for preparing Nosiheptide premixed agent |
| 01/24/2007 | CN1899306A Use of carbon and carbon containing matter inpreparing medicine for treating human body hemorrhagic syndrome and preparation and preparing method |
| 01/24/2007 | CN1899304A Eye drops for cataract and its preparing method |
| 01/24/2007 | CN1899106A Gugan synthetic substance and its preparing method and use |
| 01/24/2007 | CN1296483C Beta-lactamase/anminoglycosides passivation enzyme genes, their fusion gene and the expression products, the composition thereof, and their uses in medicine and environmental protection |
| 01/24/2007 | CN1296477C Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method |
| 01/24/2007 | CN1296384C Peptide having preptin functionality |
| 01/24/2007 | CN1296381C VEGF peptides and their use for inhibiting angiogenesis |
| 01/24/2007 | CN1296355C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/24/2007 | CN1296098C Oral insulin protecting agent |
| 01/24/2007 | CN1296094C Joint nutrient tablet |
| 01/24/2007 | CN1296052C Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/23/2007 | US7166714 Polynucleotide encoding a STEAP-1 polypeptide, used for diagnosis and treatment of prostate cancer |
| 01/23/2007 | US7166708 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 01/23/2007 | US7166704 Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer |
| 01/23/2007 | US7166699 Mosquito arrestin 1 polypeptides |
| 01/23/2007 | US7166698 Mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 01/23/2007 | US7166697 V-like domain binding molecules |
| 01/23/2007 | US7166695 Affinity markers for human serum albumin |